查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462708

LAMP（恒溫環型核酸擴增）市場至2030年的預測：按產品類型、類型、技術、應用、最終用戶和地區的全球分析

Loop-mediated Isothermal Amplification Market Forecasts to 2030 - Global Analysis By Product Type (Instruments, Kits & Reagents and Other Product Types), Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，2023年全球 LAMP（恒溫環型核酸擴增）市場規模將達到 1.035 億美元，2030年將達到 1.651 億美元，預測期內年複合成長率為 6.9%。

恒溫環型核酸擴增（LAMP）是一種核酸擴增技術，用於在恆溫條件下快速複製 DNA。使用四到六個針對 DNA 多個區域（包括環結構）的引子來啟動鏈置換和擴增。 LAMP 反應通常在 60 至 65°C 之間進行，因此不需要熱感循環設備。 LAMP方法可在30至60分鐘內產生大量DNA，可快速檢測病原體和基因突變等目標序列。由於其簡單、快速、特異性高，廣泛應用於臨床診斷、環境監測、食品安全檢測等領域。

對快速、準確診斷的需求不斷成長

對快速、準確診斷的日益成長的需求推動 LAMP 市場的成長。醫療保健提供者採用 LAMP（恒溫環型核酸擴增）技術來滿足快速檢測的需求，特別是在及時診斷非常重要的情況下，例如感染疾病爆發和緊急情況。公司投資研發，以提高其 LAMP（恒溫環型核酸擴增）檢測的靈敏度、特異性和多重功能。因此，開發了先進的基於環介導等溫擴增的診斷平台和試劑，推動了市場成長。

有限的複用能力

由於多重檢測能力有限，必須透過單獨的反應來檢測每個目標，增加了診斷所需的時間、成本和資源。這種效率和成本效益的降低可能會阻止醫療保健提供者採用 LAMP（恒溫環型核酸擴增）技術，特別是在高通量和資源效率很重要的環境中。因此，LAMP（恒溫環型核酸擴增）技術有限的連接複用能力可能使其在市場上處於競爭劣勢，鼓勵醫療保健提供者考慮選擇更能滿足其連接複用需求的替代技術，阻礙市場成長。

慢性病增加

慢性病通常需要定期監測和早期發現，以便有效管理和治療。人們越來越需要快速、準確的診斷解決方案來及早發現這些疾病。 LAMP方法快速、靈敏，適合診斷慢性疾病，可及時介入並改善患者預後。此外，世界各地的政府和醫療機構實施篩檢計劃，以及早發現慢性病，減輕疾病負擔和醫療費用。

資源有限的環境中基礎設施有限

資源有限的環境往往缺乏足夠的醫療基礎設施，例如檢測設施、訓練有素的人員和可靠的電力供應。在這種情況下，需要專門的設備和訓練有素的人員來進行 LAMP（恒溫環型核酸擴增）檢測，這可能會帶來挑戰並限制該技術的採用。此外，對不斷電系統和試劑氣候控制儲存條件的需求進一步增加了成本負擔，並使 LAMP 技術在此類環境中不太可行。

COVID-19 的影響

COVID-19 大流行加速了 LAMP（恒溫環型核酸擴增）技術的採用，以進行快速、分散的測試。 LAMP 方法簡單、快速且準確，使其成為診斷 COVID-19 的寶貴工具，尤其是在資源有限和照護現場環境中。隨著醫療保健尋求有效的測試解決方案來限制病毒的傳播，對基於 LAMP 的檢測和平台的需求迅速增加。然而，供應鏈中斷、監管挑戰以及其他診斷技術的競爭也影響疫情期間的 LAMP 市場動態。整體而言，COVID-19 既推動了 LAMP 市場的成長，也帶來了挑戰。

DNA（去氧核糖核酸）預計將成為預測期內最大的區隔。

DNA（去氧核糖核酸）區隔目的是擴增 DNA 序列，實現有利的生長。 DNA（去氧核糖核酸）區隔目的是擴增 DNA 序列，實現有利的生長。 DNA（去氧核糖核酸）區隔廣泛應用於分子生物學研究、臨床診斷以及需要快速、靈敏檢測 DNA 的各種其他領域。此外，在臨床診斷中，特定DNA序列的存在或不存在通常表示疾病狀態、基因突變或病原體感染。 LAMP（恒溫環型核酸擴增）檢測目的是以高靈敏度和特異性檢測這些 DNA 標靶。因此，能夠準確擴增和檢測目標 DNA 序列的 LAMP（恒溫環型核酸擴增）檢測的可用性影響 LAMP 市場在診斷應用中的採用和成長。

逆轉錄 LAMP 細分市場預計在預測期內年複合成長率最高

逆轉錄LAMP領域預計在預測期內將出現最高的年複合成長率，因為它允許擴增除DNA以外的RNA靶標，顯著擴大LAMP技術的應用範圍。這項擴展使得能夠檢測 RNA 病毒、基於 RNA 的生物標記和 RNA 轉錄本，為感染疾病診斷、基因表現分析和 RNA 研究提供新的機會。此外，這種能力對於基因表現譜研究、生物標記發現以及細胞對刺激和治療的反應監測非常有用，所有上述因素都在推動市場成長。

佔有率最大的地區

結核病、登革熱、瘧疾等感染疾病以及 COVID-19 等新興感染疾病在亞太地區盛行，推動了對快速診斷解決方案的需求。它提供快速、準確結果的能力對於控制疾病爆發和應對公共衛生挑戰特別有價值。此外，日本、韓國、中國和印度等國家強大的生物技術和生命科學產業推動 LAMP（恒溫環型核酸擴增）技術的研發活動，也推動了市場的成長。

年複合成長率最高的地區：

儘管醫療保健標準很高，但北美仍面臨流感、萊姆病和性行為感染傳染病等感染疾病的挑戰。 LAMP 技術快速、準確的診斷能力對該地區的醫療保健提供者很有吸引力。北美對分散式檢查解決方案的需求不斷增加，推動了市場成長，特別是在偏遠和服務不足的地區以及公共衛生緊急情況期間。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球LAMP（恒溫環型核酸擴增）市場：產品類型

  • 裝置
    • 濁度計
    • 孵化系統
    • 瓊脂糖凝膠電泳
    • 螢光測量系統
  • 套件和試劑
    • 引子
    • DNA聚合酵素
    • 緩衝液
    • 檢測試劑
  • 其他產品類型

第6章 全球 LAMP（恒溫環型核酸擴增）市場：依類型

  • DNA（去氧核糖核酸）
  • RNA（核糖核酸）

第7章 LAMP（恒溫環型核酸擴增）全球市場：依技術分類

  • 傳統LAMP
  • 逆轉錄LAMP
  • 數位LAMP
  • 等溫多重自製引子擴增（IMSPA）
  • 其他技術

第8章 LAMP（恒溫環型核酸擴增）的全球市場：依應用分類

  • 感染疾病診斷
  • 獸醫診斷
  • 分子診斷
  • 植物病害診斷
  • 生物防禦和生物安全
  • 其他用途

第9章 全球 LAMP（恒溫環型核酸擴增）市場：依最終用戶分類

  • 研究/學術機構
  • 醫院/診所
  • 獸醫診所
  • 食品和飲料業
  • 照護現場和患者附近的檢測設施
  • 生物技術和製藥公司
  • 其他最終用戶

第10章 全球LAMP（恒溫環型核酸擴增）市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Bio-Rad Laboratories, Inc.
  • CapitalBio
  • Deaou Biotechnology
  • Eiken Chemical
  • Excellgen, Inc.
  • GENESIS Dhelix
  • HiberGene Diagnostics
  • Jena Bioscience GmbH
  • Mast Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • NIPPON GENE CO., LTD
  • OptiGene
  • QIAGEN NV
  • Singuway
  • Thermo Fisher Scientific
Product Code: SMRC25759

According to Stratistics MRC, the Global Loop-mediated Isothermal Amplification Market is accounted for $103.5 million in 2023 and is expected to reach $165.1 million by 2030 growing at a CAGR of 6.9% during the forecast period. Loop-mediated isothermal amplification (LAMP) is a nucleic acid amplification technique used to rapidly replicate DNA under constant temperature conditions. It employs four to six primers targeting multiple regions of the DNA, including loop structures, which initiate strand displacement and amplification. LAMP reactions typically occur between 60-65°C, eliminating the need for thermal cycling equipment. By producing large amounts of DNA within 30-60 minutes, LAMP enables rapid detection of target sequences, such as pathogens or genetic variations. Its simplicity, speed, and high specificity make it valuable in various fields, including clinical diagnostics, environmental monitoring, and food safety testing.

Market Dynamics:

Driver:

Rising demand for rapid and accurate diagnostics

The increasing need for quick and precise diagnostics has propelled the growth of the LAMP market. Healthcare providers are adopting loop-mediated isothermal amplification technology to meet the demand for rapid testing, especially in scenarios where timely diagnosis is critical, such as infectious disease outbreaks or emergency situations. Companies are investing in research and development to improve the sensitivity, specificity, and multiplexing capabilities of loop-mediated isothermal amplification assays. This has led to the development of advanced loop-mediated isothermal amplification-based diagnostic platforms and reagents boosting the growth of the market.

Restraint:

Limited multiplexing capability

Limited multiplexing capability means that each target must be detected in a separate reaction, increasing the time, cost, and resources required for diagnostics. This reduced efficiency and cost-effectiveness can deter healthcare providers from adopting loop-mediated isothermal amplification technology, especially in settings where high throughput and resource efficiency are crucial. Thus the limited multiplexing capability of loop-mediated isothermal amplification technology can put it at a competitive disadvantage in the market, as healthcare providers may opt for alternative technologies that better meet their multiplexing needs hamper the market growth.

Opportunity:

Increasing prevalence of chronic diseases

Chronic diseases often require regular monitoring and early detection for effective management and treatment. The need for rapid and accurate diagnostic solutions to detect these diseases at an early stage has increased. LAMP technology, with its rapid turnaround time and high sensitivity, is well-suited for diagnosing chronic conditions, enabling timely intervention and improved patient outcomes. Furthermore governments and healthcare organizations worldwide are implementing screening programs to detect chronic diseases early, thereby reducing disease burden and healthcare costs.

Threat:

Limited infrastructure in resource-limited settings

Resource-limited settings often lack adequate healthcare infrastructure, including laboratory facilities, trained personnel, and reliable electricity supply. The requirement for specialized equipment and trained personnel to conduct loop-mediated isothermal amplification assays may pose accessibility challenges in such settings, limiting the adoption of this technology. Additionally, the need for uninterrupted power supply and climate-controlled storage conditions for reagents further adds to the cost burden, making LAMP technology less feasible in these environments.

Covid-19 Impact

The COVID-19 pandemic has accelerated the adoption of Loop-mediated Isothermal Amplification (LAMP) technology for rapid and decentralized testing. LAMP's simplicity, speed, and accuracy have made it a valuable tool for COVID-19 diagnostics, especially in resource-limited settings and point-of-care environments. The demand for LAMP-based assays and platforms has surged as healthcare systems seek efficient testing solutions to curb the spread of the virus. However, supply chain disruptions, regulatory challenges, and competition from other diagnostic technologies have also influenced the LAMP market dynamics during the pandemic. Overall, COVID-19 has both propelled and challenged the growth of the LAMP market.

The DNA (deoxyribonucleic acid) segment is expected to be the largest during the forecast period

The DNA (deoxyribonucleic acid) segment is estimated to have a lucrative growth, as it is designed to amplify DNA sequences. It is widely used in molecular biology research, clinical diagnostics, and various other fields where rapid and sensitive detection of DNA is required. Moreover in clinical diagnostics, the presence or absence of specific DNA sequences is often indicative of disease states, genetic mutations, or pathogen infections. Loop-mediated isothermal amplification assays are designed to detect these DNA targets with high sensitivity and specificity. Therefore, the availability of loop-mediated isothermal amplification assays that can accurately amplify and detect target DNA sequences influences the adoption and growth of the LAMP market in diagnostic applications.

The reverse transcription LAMP segment is expected to have the highest CAGR during the forecast period

The reverse transcription LAMP segment is anticipated to witness the highest CAGR growth during the forecast period, as it allows for the amplification of RNA targets, in addition to DNA, which significantly broadens the application spectrum of LAMP technology. This expansion enables the detection of RNA viruses, RNA-based biomarkers, and RNA transcripts, opening up new opportunities in infectious disease diagnosis, gene expression analysis, and RNA research. Furthermore this capability is useful in gene expression profiling studies, biomarker discovery, and monitoring cellular responses to stimuli or treatments thus all the above factors drive the market growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the prevalence of infectious diseases in the Asia Pacific region, including tuberculosis, dengue, malaria, and emerging infectious diseases like COVID-19, is driving the demand for rapid diagnostic solutions. Its ability to provide quick and accurate results is particularly valuable in controlling disease outbreaks and managing public health challenges. Additionally the presence of a robust biotechnology and life sciences industry in countries like Japan, South Korea, China, and India fosters research and development activities in loop-mediated isothermal amplification technology propel the growth of the market.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, despite high healthcare standards; North America still faces challenges related to infectious diseases such as influenza, Lyme disease, and sexually transmitted infections. LAMP technology's rapid and accurate diagnostic capabilities make it attractive for healthcare providers in the region. The demand for decentralized testing solutions is increasing in North America, especially in remote or underserved areas and during public health emergencies encourage the growth of the market.

Key players in the market

Some of the key players in the Loop-mediated Isothermal Amplification Market include Bio-Rad Laboratories, Inc., CapitalBio, Deaou Biotechnology, Eiken Chemical , Excellgen Inc, GENESIS Dhelix, HiberGene Diagnostics, Jena Bioscience GmbH, Mast Group Ltd., Merck KGaA, Meridian Bioscience, Inc., New England Biolabs, NIPPON GENE CO., LTD, OptiGene, QIAGEN N.V, Singuway and Thermo Fisher Scientific

Key Developments:

In March 2024, Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Generalized Pustular Psoriasis. This registry, which is open to enrollment, is CorEvitas' 10th syndicated disease registry and addresses an unmet need for real-world evidence (RWE) related to the clinical and patient-reported outcomes of patients with GPP.

In January 2024, Nippon Gene Co., Ltd. announced the National Agriculture and Food Research Organization (NARO) have developed two molecular-based diagnostic kits for Johne's disease.

In July 2023, Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement. The settlement provides for a cross-licensing agreement between Bio-Rad and QIAGEN granting each company mutual rights to their respective digital PCR technologies.

Product Types Covered:

  • Instruments
  • Kits & Reagents
  • Other Product Types

Types Covered:

  • DNA (Deoxyribonucleic Acid)
  • RNA (Ribonucleic Acid)

Technologies Covered:

  • Conventional LAMP
  • Reverse Transcription LAMP
  • Digital LAMP
  • Isothermal Multiple Self-Made Primer Amplification (IMSPA)
  • Other Technologies

Applications Covered:

  • Infectious Disease Diagnosis
  • Veterinary Diagnostics
  • Molecular Diagnostics
  • Plant Disease Diagnostics
  • Biodefense and Biosecurity
  • Other Applications

End Users Covered:

  • Research & Academic Institutes
  • Hospitals & Clinics
  • Veterinary Clinics
  • Food & Beverage Industry
  • Point-of-Care and Near-Patient Testing Sites
  • Biotechnology and Pharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Loop-mediated Isothermal Amplification Market, By Product Type

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Turbidimeters
    • 5.2.2 Incubation Systems
    • 5.2.3 Agarose Gel Electrophoresis
    • 5.2.4 Fluorescence Measuring Systems
  • 5.3 Kits & Reagents
    • 5.3.1 Primers
    • 5.3.2 DNA Polymerase Enzymes
    • 5.3.3 Buffers
    • 5.3.4 Detection Reagents
  • 5.4 Other Product Types

6 Global Loop-mediated Isothermal Amplification Market, By Type

  • 6.1 Introduction
  • 6.2 DNA (Deoxyribonucleic Acid)
  • 6.3 RNA (Ribonucleic Acid)

7 Global Loop-mediated Isothermal Amplification Market, By Technology

  • 7.1 Introduction
  • 7.2 Conventional LAMP
  • 7.3 Reverse Transcription LAMP
  • 7.4 Digital LAMP
  • 7.5 Isothermal Multiple Self-Made Primer Amplification (IMSPA)
  • 7.6 Other Technologies

8 Global Loop-mediated Isothermal Amplification Market, By Application

  • 8.1 Introduction
  • 8.2 Infectious Disease Diagnosis
  • 8.3 Veterinary Diagnostics
  • 8.4 Molecular Diagnostics
  • 8.5 Plant Disease Diagnostics
  • 8.6 Biodefense and Biosecurity
  • 8.7 Other Applications

9 Global Loop-mediated Isothermal Amplification Market, By End User

  • 9.1 Introduction
  • 9.2 Research & Academic Institutes
  • 9.3 Hospitals & Clinics
  • 9.4 Veterinary Clinics
  • 9.5 Food & Beverage Industry
  • 9.6 Point-of-Care and Near-Patient Testing Sites
  • 9.7 Biotechnology and Pharmaceutical Companies
  • 9.8 Other End Users

10 Global Loop-mediated Isothermal Amplification Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Bio-Rad Laboratories, Inc.
  • 12.2 CapitalBio
  • 12.3 Deaou Biotechnology
  • 12.4 Eiken Chemical
  • 12.5 Excellgen, Inc.
  • 12.6 GENESIS Dhelix
  • 12.7 HiberGene Diagnostics
  • 12.8 Jena Bioscience GmbH
  • 12.9 Mast Group Ltd.
  • 12.10 Merck KGaA
  • 12.11 Meridian Bioscience, Inc.
  • 12.12 New England Biolabs
  • 12.13 NIPPON GENE CO., LTD
  • 12.14 OptiGene
  • 12.15 QIAGEN N.V
  • 12.16 Singuway
  • 12.17 Thermo Fisher Scientific

List of Tables

  • Table 1 Global Loop-mediated Isothermal Amplification Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Loop-mediated Isothermal Amplification Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Loop-mediated Isothermal Amplification Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Loop-mediated Isothermal Amplification Market Outlook, By Turbidimeters (2021-2030) ($MN)
  • Table 5 Global Loop-mediated Isothermal Amplification Market Outlook, By Incubation Systems (2021-2030) ($MN)
  • Table 6 Global Loop-mediated Isothermal Amplification Market Outlook, By Agarose Gel Electrophoresis (2021-2030) ($MN)
  • Table 7 Global Loop-mediated Isothermal Amplification Market Outlook, By Fluorescence Measuring Systems (2021-2030) ($MN)
  • Table 8 Global Loop-mediated Isothermal Amplification Market Outlook, By Kits & Reagents (2021-2030) ($MN)
  • Table 9 Global Loop-mediated Isothermal Amplification Market Outlook, By Primers (2021-2030) ($MN)
  • Table 10 Global Loop-mediated Isothermal Amplification Market Outlook, By DNA Polymerase Enzymes (2021-2030) ($MN)
  • Table 11 Global Loop-mediated Isothermal Amplification Market Outlook, By Buffers (2021-2030) ($MN)
  • Table 12 Global Loop-mediated Isothermal Amplification Market Outlook, By Detection Reagents (2021-2030) ($MN)
  • Table 13 Global Loop-mediated Isothermal Amplification Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 14 Global Loop-mediated Isothermal Amplification Market Outlook, By Type (2021-2030) ($MN)
  • Table 15 Global Loop-mediated Isothermal Amplification Market Outlook, By DNA (Deoxyribonucleic Acid) (2021-2030) ($MN)
  • Table 16 Global Loop-mediated Isothermal Amplification Market Outlook, By RNA (Ribonucleic Acid) (2021-2030) ($MN)
  • Table 17 Global Loop-mediated Isothermal Amplification Market Outlook, By Technology (2021-2030) ($MN)
  • Table 18 Global Loop-mediated Isothermal Amplification Market Outlook, By Conventional LAMP (2021-2030) ($MN)
  • Table 19 Global Loop-mediated Isothermal Amplification Market Outlook, By Reverse Transcription LAMP (2021-2030) ($MN)
  • Table 20 Global Loop-mediated Isothermal Amplification Market Outlook, By Digital LAMP (2021-2030) ($MN)
  • Table 21 Global Loop-mediated Isothermal Amplification Market Outlook, By Isothermal Multiple Self-Made Primer Amplification (IMSPA) (2021-2030) ($MN)
  • Table 22 Global Loop-mediated Isothermal Amplification Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 23 Global Loop-mediated Isothermal Amplification Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 Global Loop-mediated Isothermal Amplification Market Outlook, By Infectious Disease Diagnosis (2021-2030) ($MN)
  • Table 25 Global Loop-mediated Isothermal Amplification Market Outlook, By Veterinary Diagnostics (2021-2030) ($MN)
  • Table 26 Global Loop-mediated Isothermal Amplification Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
  • Table 27 Global Loop-mediated Isothermal Amplification Market Outlook, By Plant Disease Diagnostics (2021-2030) ($MN)
  • Table 28 Global Loop-mediated Isothermal Amplification Market Outlook, By Biodefense and Biosecurity (2021-2030) ($MN)
  • Table 29 Global Loop-mediated Isothermal Amplification Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 30 Global Loop-mediated Isothermal Amplification Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 Global Loop-mediated Isothermal Amplification Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 32 Global Loop-mediated Isothermal Amplification Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 33 Global Loop-mediated Isothermal Amplification Market Outlook, By Veterinary Clinics (2021-2030) ($MN)
  • Table 34 Global Loop-mediated Isothermal Amplification Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 35 Global Loop-mediated Isothermal Amplification Market Outlook, By Point-of-Care and Near-Patient Testing Sites (2021-2030) ($MN)
  • Table 36 Global Loop-mediated Isothermal Amplification Market Outlook, By Biotechnology and Pharmaceutical Companies (2021-2030) ($MN)
  • Table 37 Global Loop-mediated Isothermal Amplification Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.